Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Norethindrone acetate
Drug ID BADD_D01586
Description Not Available
Indications and Usage Not Available
Marketing Status Not Available
ATC Code Not Available
DrugBank ID Not Available
KEGG ID D00953
MeSH ID D000077563
PubChem ID 5832
TTD Drug ID Not Available
NDC Product Code 60870-0236; 68462-304; 73774-009; 0555-0211; 16571-658; 64918-1404; 51285-424; 0378-7291; 50742-267
UNII 9S44LIC7OJ
Synonyms Norethindrone Acetate | Norethisterone Acetate | Estr-4-en-3-one, 17-(acetyloxy)-17-ethynyl-, (17beta)- | Norethindrone Acetate, (17alpha)-(+-)-isomer | Aygestin | Norlutate | Norethindrone Acetate, (17alpha)-isomer
Chemical Information
Molecular Formula C22H28O3
CAS Registry Number 51-98-9
SMILES CC(=O)OC1(CCC2C1(CCC3C2CCC4=CC(=O)CCC34)C)C#C
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Dizziness02.11.04.006; 24.06.02.007; 17.02.05.003--
Dysmenorrhoea21.01.01.002--
Ectropion of cervix21.06.01.004--Not Available
Endometrial cancer21.07.02.002; 16.12.02.001--Not Available
Endometrial hyperplasia21.07.01.002--Not Available
Epilepsy17.12.03.002--Not Available
Erythema multiforme23.03.01.003; 10.01.03.015--
Erythema nodosum10.02.01.020; 23.07.02.001--Not Available
Fatigue08.01.01.002--
Fibrocystic breast disease21.05.04.018; 16.14.01.003--Not Available
Flatulence07.01.04.002--
Galactorrhoea21.05.02.002; 05.03.04.002--Not Available
Gallbladder disorder09.03.02.001--Not Available
Gastroenteritis11.01.07.004; 07.19.03.001--Not Available
Genital candidiasis21.10.03.001; 11.03.03.002--Not Available
Headache17.14.01.001--
High density lipoprotein decreased13.12.01.003--Not Available
Hirsutism05.05.01.005; 23.02.04.001--
Hypersensitivity10.01.03.003--
Injury12.01.08.004--Not Available
Insomnia19.02.01.002; 17.15.03.002--
Irritability19.04.02.013; 08.01.03.011--
Jaundice cholestatic09.01.01.005--Not Available
Liver function test abnormal13.03.04.030--Not Available
Menstrual disorder21.01.01.004--Not Available
Migraine24.03.05.003; 17.14.02.001--Not Available
Mood swings19.04.03.001--Not Available
Muscle spasms15.05.03.004--
Myocardial infarction24.04.04.009; 02.02.02.007--
Nasopharyngitis22.07.03.002; 11.01.13.002--Not Available
The 2th Page    First    Pre   2 3 4    Next   Last    Total 4 Pages